Boost knowledge guided cancer therapy
Supporting the clinical decision-making process to choose the best available therapy for patients.
The clinical use of molecular modelling
Protyon creates a 3D digital model based on the genetic code of a cancer mutation. This provides detailed insights of the interaction of different drugs with the tumor, leading to predictions of the effectiveness of the available targeted therapies.
Protyon is trusted and utilized by hospitals and our partners
“Understanding how the structures of the molecules driving cancer can change will help the choice of treatments”
prof. dr. Matthew Groves
CSO Protyon BV
The Netherlands
Knowledge based prediction of treatment outcome
Protyon provides a knowledge-based approach for the selection of medication for previously unreported mutations.
Increases life expectancy of patients
Early selection of the correct treatment approach will directly impact patient outcomes.
Lowers the burden on health care
Molecular analysis techniques are becoming more cost-effective and accessible. Our technology saves costs by eliminating ineffective treatments.
Discover how molecular modeling predicts the effectiveness of targeted therapy on mutated cancer cells
Work together with Protyon
Education for clinicians
Learn how to use molecular modeling in clinical drug treament for cancer patients.
We provide a course tailored for clinicians to help them understanding how the drivers of disease look on a molecular level and how changes to these drivers impact the selection of treatment. Protyon’s course has been medically accredited by four Dutch medical associations: NVALT, NVVP, NVRO, VKGN.
Life science
Protyon provides a computational prediction of how small molecules may interact with drug targets and mutations of these drug targets.
Molecular modeling is a powerful tool that enhances the efficiency, precision, and innovation of research and development in precision medicine.
Contact us
Feel free to reach out to us and book an appointment with one of our experts in the field of molecular modeling. We are here to support you.